EUCTR2005-001893-28-IT进行中(未招募)1 期
A RANDOMIZED PHASE III TRIAL OF EXEMESTANE VERSUS ANASTROZOLE IN POSTMENOPAUSAL WOMEN WITH RECEPTOR POSITIVE PRIMARY BREAST CANCER
IBCSG0 个研究点目标入组 7,576 人开始时间: 2007年4月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 7,576
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中(未招募)
不适用
RANDOMIZED PHASE III TRIAL OF PREOPERATIVE VERSUS POSTOPERATIVE CHEMOTHERAPY WITH CISPLATIN AND GEMCITABINE IN STAGE IB-IIIA NON-SMALL CELL LUNG CANCER NSCLC - POP 01eoadjuvant treatmento for early stage non small cell lung cancerMedDRA version: 9.1Level: LLTClassification code 10061873Term: Non-small cell lung cancerEUCTR2006-002708-33-ITISTITUTI FISIOTERAPICI OSPITALIERI
进行中(未招募)
1 期
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy InfantsEUCTR2019-003306-27-CZPfizer Inc.1,200
进行中(未招募)
1 期
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy InfantsPneumococcal InfectionsMedDRA version: 21.1Level: PTClassification code 10069578Term: Pneumococcal immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2019-003306-27-PLPfizer Inc., 235 East 42nd Street, New York, NY 100171,200
进行中(未招募)
1 期
A trial to evaluate the safety and immune response of a pneumococcal conjugate vaccine in adults 18 years of age and older, who have not previously received a pneumococcal vaccinePneumococcal InfectionsMedDRA version: 20.0 Level: PT Classification code 10069578 Term: Pneumococcal immunisation System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-004279-11-SEPfizer Inc., 235 East 42nd Street, New York, NY 100173,880
进行中(未招募)
1 期
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy InfantsPneumococcal InfectionsMedDRA version: 21.1Level: PTClassification code 10069578Term: Pneumococcal immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2019-003306-27-EEPfizer Inc., 235 East 42nd Street, New York, NY 100171,200
